Wide Ranks

LH

Labcorp Holdings Inc.

242.15

Top Statistics
Market Cap 20 B Forward PE 15.17 Revenue Growth 7.40 %
Current Ratio 1.44 Trailing PE 45.86 Earnings Growth -5.20 %
Profit Margins 3.43 % Peg Ratio Dividend Yield 1.19 %
Enterprice / EBITA 15.85 Enterprise / Revenue 2.09 Price To Sales Trailing12 Months 1.59
Profitability
Profit Margins 3.43 % Operating Margins 8.29 %
Balance Sheet
Total Cash 1 B Total Cash Per Share 18.14 Total Debt 7 B
Total Debt To Equity 95.00 Current Ratio 1.44 Book Value Per Share 97.61
All Measures
Short Ratio 293.00 % Message Board Id finmb_30643 Shares Short Prior Month 1 M
Return On Equity 0.0543 City Burlington Uuid 2b9645dc-7a42-3738-ac9f-a5a75117b1c0
Previous Close 238.73 First Trade Date Epoch Utc 638 M Book Value 97.61
Beta 1.04 Total Debt 7 B Volume 444124
Price To Book 2.48 Last Split Date 1 B Fifty Two Week Low 191.97
Total Cash Per Share 18.14 Total Revenue 12 B Shares Short Previous Month Date 1 B
Target Median Price 263.00 Max Age 86400 Recommendation Mean 1.78
Sand P52 Week Change 0.3133 Operating Margins 8.29 % Last Dividend Value 0.7200
Target Mean Price 261.06 Net Income To Common 435 M Ask 248.99
Short Percent Of Float 0.0356 Implied Shares Outstanding 83 M Last Fiscal Year End 1 B
Trailing Peg Ratio 51.80 % Average Daily Volume10 Day 742320 Average Volume10days 742320
Total Cash 1 B Next Fiscal Year End 1 B Revenue Per Share 151.03
Held Percent Insiders 0.0033 Ebitda Margins 13.16 % Dividend Rate 2.88
Trailing PE 45.86 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 238.73 Target Low Price 231.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 226.96 Open 239.53 Dividend Yield 1.19 %
State NC Free Cashflow 694 M Return On Assets 0.0396
Time Zone Short Name EST Trailing Eps 5.28 Day Low 238.75
Address1 358 South Main Street Trailing Annual Dividend Rate 2.88 Price Hint 2
Shares Outstanding 83 M Target High Price 293.00 Website https://www.labcorp.com
52 Week Change 0.1164 Average Volume 598810 Earnings Quarterly Growth -7.60 %
Forward Eps 16.02 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 109.70 % Last Split Factor 1164:1000 Regular Market Day High 242.42
Is_sp_500 True Profit Margins 3.43 % Debt To Equity 95.00
Fifty Two Week High 247.99 Day High 242.42 Shares Short 2 M
Regular Market Open 239.53 Industry Key diagnostics-research Bid 232.00
Earnings Growth -5.20 % Enterprise To Revenue 2.09 Revenue Growth 7.40 %
Shares Percent Shares Out 0.0267 Operating Cashflow 1 B Currency USD
Time Zone Full Name America/New_York Market Cap 20 B Is_nasdaq_100 False
Zip 27215 Payout Ratio 54.65 % Quote Type EQUITY
Industry Diagnostics & Research Ex Dividend Date 1 B Regular Market Day Low 238.75
Held Percent Institutions 0.9481 Long Name Labcorp Holdings Inc. Current Price 242.15
Enterprise To Ebitda 15.85 Financial Currency USD Trailing Annual Dividend Yield 1.21 %
Current Ratio 1.44 Gross Margins 27.92 % Industry Disp Diagnostics & Research
Number Of Analyst Opinions 16 Country United States Float Shares 83 M
Two Hundred Day Average 215.73 Enterprise Value 26 B Price To Sales Trailing12 Months 1.59
Forward PE 15.17 Regular Market Volume 444124 Last Dividend Date 1 B
Ebitda 1 B Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Labcorp Holdings Inc. provides laboratory services.

It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services.

The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs).

In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing.

It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers.

The company was founded in 1995 is headquartered in Burlington, North Carolina.